NASDAQ : AGRX
$0.05 (3.42%)
NASDAQ
Alfred F. Altomari
Drug Manufacturers - Specialty & Generic
Healthcare
AGRX
19
US
USD
-0.13
0.46
0.33
0.12
0.00
$19.59M
0.53
-0.20
-1.09
-4.44
-$6.71
-$14.46M
-73.83%
-73.83%
132.32%
-141.05%
-0.23
0.00
0.00
$1.00
$1.00
$1.00
0/5
10 Analysts
51.00%
-41.24
3/9
-$11.78M
$14.96M
$36.88M
-$6M
$10.04M
0.51
-0.79
0.46
132.32%
235.31%
-444.17%
-91.86%
-215 days
| Name | Title |
|---|---|
| Geoffrey Gilmore | Senior Vice President, Chief Administrative Officer & Corporate Secretary |
| Robert G. Conway | Senior Vice President and Chief Corporate Planning & Supply Chain Officer |
| Paul Korner | Senior Vice President & Chief Medical Officer |
| Alfred F. Altomari | Chairman, President & Chief Executive Officer |
| Scott Coiante | Chief Financial Officer, Senior Vice President & Treasurer |
| Amy Welsh | Senior Vice President & Chief Commercial Officer |
No votes yet today — be the first to share your view!
About Agile Therapeutics, Inc. (NASDAQ:AGRX) Stock
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive ... cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Frequently Asked Questions
What is the current Agile Therapeutics, Inc. (AGRX) stock price?
Agile Therapeutics, Inc.(NASDAQ:AGRX) stock price is $1.51 in the last trading session. During the trading session, AGRX stock reached the peak price of $2.63 while $0.2 was the lowest point it dropped to. The percentage change in AGRX stock occurred in the recent session was 3.42% while the dollar amount for the price change in AGRX stock was $0.05.
AGRX's industry and sector of operation?
The NASDAQ listed AGRX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of AGRX?
Geoffrey Gilmore
| Senior Vice President, Chief Administrative Officer & Corporate Secretary
Robert G. Conway
| Senior Vice President and Chief Corporate Planning & Supply Chain Officer
Paul Korner
| Senior Vice President & Chief Medical Officer
Alfred F. Altomari
| Chairman, President & Chief Executive Officer
Scott Coiante
| Chief Financial Officer, Senior Vice President & Treasurer
How many employees does AGRX have?
Number of AGRX employees currently stands at 19. AGRX operates from 500 College Road East, Princeton, NJ 08540, US.
Link for AGRX official website?
Official Website of AGRX is: https://www.agiletherapeutics.com
How do I contact AGRX?
AGRX could be contacted at phone #609 683 1880 and can also be accessed through its website. AGRX operates from 500 College Road East, Princeton, NJ 08540, US.
How many shares of AGRX are traded daily?
The average number of AGRX shares traded daily for last 3 months was 154.55K.
What is the market cap of AGRX currently?
The market value of AGRX currently stands at $10.43M with its latest stock price at $1.51